---
**Patient Name:** Tamie Goldner  
**MRN:** 004839201  
**DOB:** 1964-04-14  
**Sex:** F  
**Admit Date:** 2024-03-28  
**Attending:** Dr. R. Fillmore (Cardiology/ICU)  
**Consults:** Cardiology, CT Surgery, Oncology, Endocrinology  
**Allergies:** NKDA  
**Code Status:** Full Code  
**Height:** 159.7 cm  
**Weight:** 70.5 kg  
**BMI:** 27.7  
**Admitting Dx:** Cardiogenic shock secondary to acute decompensated heart failure; hx of breast CA  
**Disposition:** ICU  

---

## HOSPITAL COURSE SUMMARY

Ms. Tamie Goldner is a 59-year-old female with a significant PMHx including HTN, breast cancer s/p L mastectomy (2019), multiple pregnancies (incl. tubal), and recent viral illness, who presented to the ED with acute onset dyspnea, orthopnea, chest heaviness, and lower extremity edema. She was found to be in acute decompensated heart failure with hypotension refractory to IV diuresis and pressors, requiring transfer to the cardiac ICU and placement of a temporary left ventricular assist device (Impella CP) for hemodynamic support. Her ICU course was complicated by AKI, mild transaminitis, and delirium. She was successfully weaned from the pump after 4 days, transitioned to oral HF regimen, and is currently being evaluated for advanced therapies.

---

## ASSESSMENT & PLAN

### 1. Cardiogenic Shock / Acute Decompensated Heart Failure (ADHF)
- **History:** Presented with SOB, orthopnea, PND, mild CP. Hx HTN, possible prior anthracycline exposure (onc hx).  
- **Exam:** JVD, bibasilar crackles, S3, pitting edema.  
- **Workup:**  
  - CXR: Pulmonary vascular congestion, mild effusions  
  - Echo: EF 18%, global hypokinesis, mild MR  
  - BNP 3420, troponin 0.18 → 0.25 (no dynamic change)  
  - Cardiac cath: no significant CAD  
- **Course:** Initial management with IV furosemide, dobutamine, and norepinephrine. Rapid progression to hypotension (MAP <60) and rising lactate (4.8). Emergent Impella CP placed at bedside.  
- **Status:** Weaned from pressors and Impella on HD5, EF up to 26% on repeat TTE.  
- **Plan:** Continue GDMT for HF (carvedilol, sacubitril/valsartan, spironolactone), daily weights, strict I/Os, monitor for arrhythmia. Cardiac rehab consult. Consider advanced therapies if recurrent decompensation.

### 2. AKI (secondary to low cardiac output, nephrotoxic exposure)
- **Exam:** Oliguria on HD2-3  
- **Labs:** Cr up from 1.1 → 2.4, BUN 48, K peaked at 5.3.  
- **Course:** Improved with restoration of perfusion, careful diuresis, avoidance of nephrotoxins.  
- **Plan:** Monitor renal function, avoid NSAIDs, nephrology PRN.

### 3. Malignant Neoplasm of Breast – hx L mastectomy (2019), no recurrence
- **Status:** No evidence of recurrence on recent mammo, CEA 2.1, CA 15-3 wnl.  
- **Plan:** Routine oncology f/u, continue tamoxifen.

### 4. Hypertension
- **Course:** Difficult to control during shock, now stable.  
- **Plan:** Resume HCTZ, uptitrate as tolerated given renal function. Monitor BP q4h.

### 5. Delirium
- **Exam:** ICU psychosis, fluctuating attention, sleep-wake disordered  
- **Plan:** Reorient, minimize sedation, optimize sleep, PT/OT.

### 6. Hx: Tubal Pregnancy, multiple normal pregnancies, 1st trimester miscarriage
- **Plan:** Gyn f/u as outpatient.

### 7. Other PMHx (sinusitis, bronchitis, ankle sprain, thigh lac)
- **Plan:** No current issues.

### 8. DVT Prophylaxis
- **Plan:** SCDs, lovenox 40mg qd while in ICU.

### 9. Nutrition
- **Plan:** Cardiac diet, salt restriction, monitor lytes.

---

## ICU DAILY PROGRESS NOTE (Select Days)

**HD1 (03/28/24):**  
- Vitals: T 36.5C, HR 116, BP 82/55 (MAP 62), RR 24, SpO2 93% RA  
- Exam: Alert, anxious, mild distress, cool extremities  
- Interventions: IV furosemide, started dobutamine, norepi drip.  
- Labs: See below.

**HD2 (03/29/24):**  
- Vitals: T 37.2, HR 108, BP 89/61  
- Exam: Somnolent, decreased UOP  
- Interventions: Impella CP placed.  
- Labs: See below.

**HD3 (03/30/24):**  
- Vitals: T 36.8, HR 98, BP 102/67  
- Exam: Improved perfusion, mild delirium  
- Interventions: Weaning pressors.

**HD5 (04/01/24):**  
- Vitals: T 36.6, HR 85, BP 118/70  
- Exam: Awake, alert, extubated, Impella removed.  
- Interventions: Transition to oral meds.

---

## LABS

| Date       | WBC (K/uL) | Hgb (g/dL) | Plt (K/uL) | Na (mmol/L) | K (mmol/L) | Cl (mmol/L) | HCO3 (mmol/L) | BUN (mg/dL) | Cr (mg/dL) | Glu (mg/dL) | AST (U/L) | ALT (U/L) | BNP (pg/mL) | Troponin (ng/mL) |
|------------|------------|------------|------------|-------------|------------|-------------|---------------|-------------|------------|-------------|-----------|-----------|-------------|------------------|
| 03/28/24   | 5.4        | 17.1       | 301        | 135         | 4.1        | 101         | 23            | 28          | 1.1        | 112         | 41        | 37        | 3420        | 0.18             |
| 03/29/24   | 8.9        | 14.7       | 277        | 132         | 5.3        | 98          | 21            | 48          | 2.4        | 109         | 89        | 72        | 3980        | 0.25             |
| 03/30/24   | 7.2        | 13.8       | 245        | 137         | 4.7        | 104         | 26            | 38          | 1.6        | 124         | 52        | 60        | 2200        | 0.21             |
| 03/31/24   | —          | 12.6       | 233        | 139         | 4.5        | 106         | —             | 30          | 1.2        | —           | —         | —         | 1350        | —                |
| 04/01/24   | 6.1        | 13.9       | 255        | 140         | 4.2        | 105         | 25            | 22          | 1.1        | 98          | 38        | 31        | 980         | 0.19             |

---

## ACTIVE MEDICATIONS

- Furosemide IV 80mg BID (now PO 40mg BID)
- Carvedilol 3.125mg BID (initiated HD4)
- Sacubitril/Valsartan 24/26mg BID (initiated HD5)
- Spironolactone 25mg QD
- HCTZ 25mg QD (resumed HD5)
- Tamoxifen 20mg QD
- Acetaminophen 325mg PRN
- Lovenox 40mg SQ QD
- PRN: O2, naproxen (held), seasonique/trinessa (home, held inpatient)

---

## IMAGING

- **CXR (03/28/24):** Pulmonary edema, mild bilateral effusions, enlarged cardiac silhouette.
- **TTE (03/28/24):** EF 18%, global hypokinesis.
- **TTE (04/01/24):** EF improved to 26%, mild MR.

---

## CONSULTS

- **Cardiology:** LVAD candidacy, advanced HF therapies.
- **CT Surgery:** Impella management, removal.
- **Oncology:** No evidence of active malignancy.
- **Nephrology:** AKI management, now resolved.

---

## DISCHARGE PLANNING

- **Anticipated discharge:** 2-3 days
- **Disposition:** Home with cardiac rehab
- **Follow-up:** Cardiology, oncology, nephrology, primary care
- **Education:** HF self-management, medication adherence, salt restriction

---

## ADDITIONAL NOTES

- No new issues with prior OB/GYN history.
- No signs of infection, negative blood cultures.
- Delirium resolving, sleep-wake cycle improved.
- No bleeding or vascular complications from Impella.

---

**Attestation:**  
I have personally examined the patient and reviewed the data above.  
**Dr. R. Fillmore, MD**  
**Date:** 04/02/2024

---
